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The consumption of probiotics has been reported to induce a range of benefits for human health, including the prevention of necrotizing enterocolitis in premature infants \[[@CR1]\], crying time reduction in colicky babies \[[@CR2]\], reduction in acute pediatric diarrhea duration \[[@CR3]\], symptom management in irritable bowel syndrome \[[@CR4]\], and prevention of antibiotic-associated diarrhea \[[@CR5]\]. The underlying mechanism for probiotic functionality is often assumed to stem from their ability to impact the human microbiota. However, in a study recently published by Kristensen et al. \[[@CR6]\], the conclusion is that the probiotics tested thus far do not have a substantive effect on the overall composition of colonizing gut microbes in healthy adults. Nevertheless, this finding should not be interpreted to mean that probiotics have no effect on healthy adults; indeed, numerous controlled intervention trials argue otherwise. However, Kristensen et al.'s \[[@CR6]\] study does suggest that an alteration in gut microbiota composition is not a primary mechanism of probiotic functionality.

The extent of the evidence considered in Kristensen et al.'s \[[@CR6]\] review comprises seven randomized controlled trials that assessed fecal samples from healthy subjects using shotgun metagenomic sequencing, 16S rRNA sequencing, or phylogenetic microarray methods. While most of the included studies covered *Lactobacillus* probiotics, the review also included one study each for *Bifidobacterium longum* or *Bacillus subtilis*. Using a systematic approach, the authors found no effect of probiotics on fecal microbiota composition when compared to a placebo, as reflected by alpha-diversity, richness, or evenness. Not included in the Kristensen et al. \[[@CR6]\] study were pre-metagenomic studies, which have demonstrated that probiotic consumption often increases the number of related phylotypes and, in some cases, decreases opportunistic pathogens and their toxins \[[@CR7]\]. Such limited effects are likely masked in comprehensive metagenomics assessments. These limited compositional changes notwithstanding, Kristensen et al.'s \[[@CR6]\] review challenges us to reconsider assumptions regarding the mechanisms behind the documented efficacy of probiotics.

Probiotic impact on the microbiota {#Sec2}
----------------------------------

Although outside the scope of the review by Kristensen et al. \[[@CR6]\], another aspect that should be considered is whether or not probiotics exert an effect on the function of microbiota as reflected by metatranscriptomic and metabolomic analyses. Indeed, Eloe-Fadrosh et al. \[[@CR8]\] and McNulty et al. \[[@CR9]\] have described such effects. However, relevance to human health of the metabolic changes observed thus far remains to be elucidated. The same can be said for compositional changes. We do not know how colonizing populations are established or the causes of their variability over time. At any given moment, gut microbiota composition is impacted by so many host and environmental variables that it is difficult to form meaningful hypotheses. This point is clearly made through a recent microbiome analysis of fecal samples from a total of 3948 healthy subjects, tracking just over 500 metadata variables \[[@CR10]\]. Sixty-nine factors were shown to correlate significantly with overall microbiome community variation reflected in alpha-diversity and abundances, yet these variables explained only a small fraction of the variation of genera present in the communities. Even this large study was not able to determine the essential factors responsible for determining the composition of our gut microbiota.

A pressing topic in the probiotic field today is whether or not probiotics can impact gut microbiota in a manner that improves the health of the host. Unfortunately, since the composition of a healthy microbiota remains unknown \[[@CR11]\], there is a lack of robust phylogenetic targets for exploratory research. Rather than focusing on specific phylogenetic changes in composition, a more fruitful approach could be to assess the ability of probiotics to promote microbiota stability \[[@CR12]\]. Although not a new concept, surprisingly few studies have addressed the ability of a probiotic to reinforce the colonizing microbiota's ability to either resist perturbation to stressors (for example, antibiotics, poor diet, psychological stress) or quicken recovery from said stress. Engelbreckston et al. \[[@CR13]\] showed less antibiotic-induced microbiota disruption in healthy, probiotic-supplemented adults than in those who did not take a probiotic. Their study assessed microbiota changes using both culture techniques and terminal restriction fragment length polymorphism. Studies comparing metagenomic composition before and after a stress, with and without a probiotic intervention, could provide insights into the ability of probiotics to support host health through stabilizing the microbiota, rather than fundamentally changing its composition (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1The concept of homeostasis as expressed by reducing the magnitude or duration of the impact of a stress on the microbiota. Modified from Sanders et al. \[[@CR12]\], no permission required
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Kristensen et al. \[[@CR6]\] have provided incentives to revise our assumptions of how probiotics might promote health in humans. Additional research is needed to clarify whether probiotics can instead promote gut microbiota homeostasis and thereby minimize the far reaching effects of microbiota disturbances. Such research may help resolve this apparent contradiction between the clear health benefits of probiotics and their lack of impact on microbiota composition.
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